SOLIFENACIN APOTEX
5MG TBL FLM 30 I
SÚKL code | 0192867 |
---|---|
Name of the product | SOLIFENACIN APOTEX |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | SOLIFENACIN APOTEX |
Supplement | 5MG TBL FLM 30 I |
Strenght | 5MG |
Pharmaceutical form | Film-coated tablet |
Package | 30 I |
Route | Oral use |
Language of the pack | Czech |
Wrap type | Blister |
Legal status | na lékařský předpis |
Active substance | SOLIFENACIN SUCCINATE (SOLIFENACINI SUCCINAS) |
ATC group | G04BD08 |
ATC group name | SOLIFENACIN |
Marketing authorisation information
Registration Number | 73/ 236/12-C |
---|---|
Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Reference member state |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 31. 08. 2020 |
MA Holder | Apotex Europe B.V., Leiden |
MA Holder country | NIZOZEMSKO |
Actual MA holder | Aurovitas, spol. s r.o., Praha |
Actual MA holder country | ČESKÁ REPUBLIKA |